At Minutia Katy Digovich is tackling diabetes cell by cell


For Minutia CEO Katy Digovich, diabetes is a personal and professional challenge. Her company is developing potentially game-changing cell therapies.

Previous Trozzolo's Prairie Dog creates new executive role to catapult growth
Next See which communities in the Pittsburgh region are the most educated